Minoxidil

Minoxidil, the active ingredient in this oral formulation, is a potassium channel opener presented as an oral tablet for oral use. It is employed to lower blood pressure in patients with severe hypertension that does not respond to standard therapy.

GNH USA supplies Minoxidil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil is used in the management of hypertension, acting on vascular smooth muscle to reduce systemic resistance.

- Severe resistant hypertension: lowers blood pressure when other antihypertensive agents have failed. - Refractory hypertension: used as an adjunct to existing therapy to achieve target pressures. - Hypertensive crisis (inpatient setting): may be administered under specialist supervision for rapid blood‑pressure control.

Minoxidil may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Fluid retention: peripheral edema, weight gain. - Tachycardia: increased heart rate, palpitations. - Hypertrichosis: excessive hair growth on face and body. - Headache: mild to moderate intensity. - Dizziness: especially on standing. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Pericardial effusion: accumulation of fluid around the heart. - Myocardial ischemia: chest pain due to reduced coronary blood flow. - Severe hypotension: dangerously low blood pressure. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatotoxicity: abnormal liver function tests. - Anaphylaxis: rare systemic allergic reaction.

Before initiating therapy, clinicians should evaluate cardiovascular status and monitor for fluid overload.

- Baseline assessment: obtain blood pressure, heart rate, and cardiac function tests. - Concomitant diuretics: consider to mitigate edema, but monitor electrolytes. - Beta‑blockers: may be required to control reflex tachycardia. - Pregnancy: use only if potential benefit justifies risk, as safety data are limited. - Breastfeeding: avoid unless benefits outweigh potential infant exposure. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Minoxidil can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may exacerbate tachycardia and reduce antihypertensive effect. - Central alpha‑agonists (e.g., clonidine): can cause severe hypertension rebound if discontinued abruptly. - MAO inhibitors: potential for unpredictable blood‑pressure changes.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: increase risk of electrolyte imbalance and dehydration. - ACE inhibitors or ARBs: additive blood‑pressure lowering effect, monitor for hypotension. - Calcium channel blockers: may enhance vasodilatory response, requiring dose adjustments.